Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RETAIN: Extended Follow-up of Ranibizumab in RVO
NCT01198327Phase 3Completed
- Sponsor
- Peter A Campochiaro
- Start
- Aug 2010
- Primary completion
- Dec 2012
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ranibizumab in macular edema, sponsored by Peter A Campochiaro. Started Aug 2010; status: completed.
02
Drugs
ranibizumab
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT01198327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198327.